Can stem cells be engineered to battle brain cancer?

Treating glioblastoma multiforme (GBM) – the most common and aggressive form of brain cancer – is notoriously difficult. In the early 2000s, researchers began investigating a new form of therapy to attack GBM tumors: implanting stem cells engineered to express toxins that specifically kill tumor cells. The toxin – a protein called TRAIL – kills tumor cells (but not normal cells!) ┬áby signaling through a … Continue reading Can stem cells be engineered to battle brain cancer?

EBC-46, a novel PKC inhibitor shows pre-clinical potential

New cancer drug promising, but has a long way to go

A recent article published in Medical Express last week touts the impressive findings of a pre-clinical study on the experimental drug EBC-46 (pictured above). In the article, they claim that EBC-46 is able to effectively destroy tumors by destroying the blood vessels that supply it with oxygen and nutrients. It is important, however, to remember that the work they are reporting on is very preliminary … Continue reading New cancer drug promising, but has a long way to go